Medical Spectroscopy
News
-
New Bone Data Comparing ImpediMed’s SOZO to DXA in Cancer Patients to be Presented at 39th Annual Miami Breast Cancer Conference
ImpediMed Limited (ASX.IPD), a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health is pleased to announce an abstract comparing concurrent measures using ...
Equipment & Solutions
-
Showcase
Single-channel, Tetrapolar Bioimpedance Spectroscopy (BIS) Device
ImpediMed SFB7 measures fluid status and tissue composition for clinical and research applications. This single-channel, tetrapolar BIS device has been used to analyze body composition in healthy individuals and over 40 various disease states or medical conditions.